AstraZeneca Pauses UK Investment: A Blow to Britain?
Update: 2025-09-12
Description
AstraZeneca halts £200M UK investment, jeopardizing 1,000 jobs, just months after unveiling the project. This follows Merck's cancellation of a London research hub, intensifying concerns about Britain's business climate. With the economy struggling and Trump's visit looming, pressure mounts on the government to address big pharma's grievances over undervalued medicines and slow innovation, as companies like AstraZeneca shift investments to the US.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
